Diazepam Tablet
Product Images NDC 59651-652

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Diazepam (NDC 59651-652). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fig1 (Diazepam Fig1)

FDA Label Image

Fig2 (Diazepam Fig2)

Fig2 (Diazepam Fig2)
This text appears to be a description of a medication. It provides information about the composition of the tablet (containing Diazepam USP 5 mg), the manufacturer (Aurabindo Pharma USA, Inc.), and the address of the company. It mentions that the tablets should be stored in a light-resistant container, and provides the recommended temperature range for storage. The text also mentions that the medication should be dispensed by a pharmacist and that a medication guide should be provided to each patient. It includes a code related to the manufacturing of the tablets and provides a website for printing medication guides. Additionally, it mentions that certain details (such as the GTIN, Serial Number, Expiry Date, and LOT) will be printed during packing. However, the last part of the text is not readable due to dotted lines.*
FDA Label Image

Fig3 (Diazepam Fig3)

FDA Label Image

Chemical Structure (Diazepam Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.